
Journal of Medicinal Chemistry p. 560 - 567 (1982)
Update date:2022-08-03
Topics:
Wiley, Paul F.
Elrod, David W.
Houser, David J.
Richard, Floyd A.
Nogalamycin (1) has been modified by changes at C-10 and C-7 and in the dimethylamino group to prepare an extensive series of analogues.The chemistry involved in the modifications and structure-activity relationships among these nogalamycin analogues are discussed, as well as comparisons with previously reported compounds 1, 7-con-O-methylnogarol (2), and disnogamycin (11).
View MoreWuhan Shangrisyn chemicals Technology Co.,Ltd(expird)
Contact:+86-027-84466317 __ +86-15387123698
Address:wuhan - china
Contact:+86-519-8525-2752
Address:Changzhou
Hangzhou Showland Technology Co., Ltd.
Contact:86-571-88920516
Address:ROOM2118,NO.553,WENSAN ROAD,HANGZHOU,CHINA
Jinhua City Mingzhu Pharmaceutical Co.,Ltd.
Contact:15857995878 0579-82207761
Address:No.169 Shenze Road, New Area,Jinpan Development Zone, Jinhua
website:http://www.sigmaaldrich.com
Contact:800 558-9160
Address:Industriestrasse 25CH-9471 Buchs SGSwitzerland
Doi:10.1039/P19820002663
(1982)Doi:10.1016/j.tetlet.2006.02.017
(2006)Doi:10.1021/ja00803a020
(1973)Doi:10.1080/00397919608003548
(1996)Doi:10.1016/S0008-6215(00)84935-6
(1972)Doi:10.1002/adsc.200600584
(2007)